Woodline Partners LP

Position in VKTX — Viking Therapeutics, Inc.

CIK 1784547 San Francisco, CA

Position in VKTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,851,517

-$773,968 QoQ

Shares Held

302,751

+0.2% QoQ

Ownership

0.261%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. VKTX ranks #83 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,851,517	302,751	+0.2%	Shares	Sole	2026-05-15
2025-12-31	$10,625,485	302,032	+0.0%	Shares	Sole	2026-02-17
2025-09-30	$7,936,402	301,994	+0.3%	Shares	Sole	2025-11-14
2025-06-30	$7,981,720	301,197	+0.0%	Shares	Sole	2025-08-14
2025-03-31	$7,271,033	301,078	+222.7%	Shares	Sole	2025-05-15
2024-12-31	$3,754,150	93,294	+46.2%	Shares	Sole	2025-02-14
2024-09-30	$4,040,380	63,819	-2.5%	Shares	Sole	2024-11-14
2024-06-30	$3,468,232	65,426	+0.2%	Shares	Sole	2024-08-14
2024-03-31	$5,355,256	65,308	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.